Logotipo do repositório
 

Publicação:
Misoprostol and teratogenesis in neonates

dc.contributor.authorScabora da Silva, Mariana Beatriz [UNESP]
dc.contributor.authorFerreira, Aline de Assis [UNESP]
dc.contributor.authorHabr, Soraya Ferreira [UNESP]
dc.contributor.authorBernardi, Maria Martha [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2020-12-10T16:35:10Z
dc.date.available2020-12-10T16:35:10Z
dc.date.issued2009-07-01
dc.description.abstractThis paper is focused in some aspects of maternal exposure to misoprostol during perinatal period, and the abortive and teratogenesis effects on the fetus. The causes of malformations were revised, taking into account chemical, physical and environmental factors as well as the interaction between them. There are evidences that the practice of abortion tripled in Southern and Northeaster Brazil in 15 years, and one of the most frequent forms of abortion is through the use of misoprostol. In Brazil, 1991, 288,700 women were hospitalized as a consequence of complications induced by abortion attempt with this medicine. This fact resulted in the ban of misoprostol across our country, by Decree 344/98 determined by the Health Ministry. The use of misoprostol requires special control and it is allowed only in hospitals, with supervision of the municipal health surveillance. Among the more severe problems affecting the non-aborted child is the injury on the central nervous system, which frequently results in the Moebius syndrome. This is a congenital and non-progressive paralysis of the VI and VII cramal nerves, frequently bilateral, which produces a unexpressive facial appearance and convergent Strabismus. Even banned in our country, abortion is illegally practiced, being deprived of proper knowledge about misoprostol teratogenic effects on the fetus as well as the risks involving mothers.en
dc.description.affiliationUniv Estadual Paulista, Inst Ciencias Saude, Dept Pathol, BR-04182020 Sao Paulo, Brazil
dc.description.affiliationUniv Sao Paulo, Fac Vet Med & Zootech, Dept Pathol, Dept Pharmacol, BR-05508 Sao Paulo, Brazil
dc.description.affiliationUniv Sao Paulo, Inst Biomed Sci, Dept Pharmacol, BR-05508 Sao Paulo, Brazil
dc.description.affiliationUnespUniv Estadual Paulista, Inst Ciencias Saude, Dept Pathol, BR-04182020 Sao Paulo, Brazil
dc.format.extent417-422
dc.identifierhttp://dx.doi.org/10.1590/S1984-82502009000300005
dc.identifier.citationBrazilian Journal Of Pharmaceutical Sciences. Sao Paulo: Univ Sao Paulo, Conjunto Quimicas, v. 45, n. 3, p. 417-422, 2009.
dc.identifier.doi10.1590/S1984-82502009000300005
dc.identifier.issn1984-8250
dc.identifier.urihttp://hdl.handle.net/11449/194710
dc.identifier.wosWOS:000272926700005
dc.language.isoeng
dc.publisherUniv Sao Paulo, Conjunto Quimicas
dc.relation.ispartofBrazilian Journal Of Pharmaceutical Sciences
dc.sourceWeb of Science
dc.subjectPerinatal toxicology
dc.subjectMisoprostol Malformations
dc.subjectMoebius syndrome
dc.subjectAbortion Cytotee
dc.titleMisoprostol and teratogenesis in neonatesen
dc.typeArtigo
dcterms.rightsHolderUniv Sao Paulo, Conjunto Quimicas
dspace.entity.typePublication
unesp.author.orcid0000-0002-6860-9416[4]

Arquivos

Coleções